Portfolio company
BE Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neuroplast
This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.
NovaGo Therapeutics
This clinical-stage biotechnology company develops human antibody therapeutics to promote nerve regeneration for patients with spinal cord injuries and strokes.
Neurona Therapeutics
This company develops off-the-shelf regenerative neural cell therapies for patients with drug-resistant epilepsy and other chronic disorders of the central nervous system.
Savanna Biotherapeutics
This company develops induced pluripotent stem cell-derived microglia cell therapies to treat patients with neurodegenerative diseases and other central nervous system disorders.
Cellergy Therapeutics
This biotechnology company develops purified mitochondrial transplantation therapies to treat patients with neurodegenerative diseases, muscle degeneration and age-related conditions.
ONWARD Medical
This company develops spinal cord stimulation systems to restore movement and function in people with spinal cord injuries and Parkinson's disease.
Neuro
Mangrove Neuro develops cell and tissue replacement therapies, specifically cortical grafts, for patients suffering from neurodegeneration and brain trauma.
Reservoir Neuroscience
The company develops therapeutics to repair the blood-brain barrier for patients with age-related neurodegeneration and chronic epilepsy.
